Literature DB >> 17028317

Contribution of growth and cell cycle checkpoints to radiation survival in Drosophila.

Burnley Jaklevic1, Lyle Uyetake, Willy Lemstra, Julia Chang, William Leary, Anthony Edwards, Smruti Vidwans, Ody Sibon, Tin Tin Su.   

Abstract

Cell cycle checkpoints contribute to survival after exposure to ionizing radiation (IR) by arresting the cell cycle and permitting repair. As such, yeast and mammalian cells lacking checkpoints are more sensitive to killing by IR. We reported previously that Drosophila larvae mutant for grp (encoding a homolog of Chk1) survive IR as well as wild type despite being deficient in cell cycle checkpoints. This discrepancy could be due to differences either among species or between unicellular and multicellular systems. Here, we provide evidence that Grapes is needed for survival of Drosophila S2 cells after exposure to similar doses of IR, suggesting that multicellular organisms may utilize checkpoint-independent mechanisms to survive irradiation. The dispensability of checkpoints in multicellular organisms could be due to replacement of damaged cells by regeneration through increased nutritional uptake and compensatory proliferation. In support of this idea, we find that inhibition of nutritional uptake (by starvation or onset of pupariation) or inhibition of growth factor signaling and downstream targets (by mutations in cdk4, chico, or dmyc) reduced the radiation survival of larvae. Further, some of these treatments are more detrimental for grp mutants, suggesting that the need for compensatory proliferation is greater for checkpoint mutants. The difference in survival of grp and wild-type larvae allowed us to screen for small molecules that act as genotype-specific radiation sensitizers in a multicellular context. A pilot screen of a small molecule library from the National Cancer Institute yielded known and approved radio-sensitizing anticancer drugs. Since radiation is a common treatment option for human cancers, we propose that Drosophila may be used as an in vivo screening tool for genotype-specific drugs that enhance the effect of radiation therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028317      PMCID: PMC1698627          DOI: 10.1534/genetics.106.064477

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  32 in total

1.  Drosophila p53 binds a damage response element at the reaper locus.

Authors:  M H Brodsky; W Nordstrom; G Tsang; E Kwan; G M Rubin; J M Abrams
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

2.  DNA damage-induced activation of p53 by the checkpoint kinase Chk2.

Authors:  A Hirao; Y Y Kong; S Matsuoka; A Wakeham; J Ruland; H Yoshida; D Liu; S J Elledge; T W Mak
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

3.  The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01.

Authors:  P R Graves; L Yu; J K Schwarz; J Gales; E A Sausville; P M O'Connor; H Piwnica-Worms
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

4.  Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4.

Authors:  R Böhni; J Riesgo-Escovar; S Oldham; W Brogiolo; H Stocker; B F Andruss; K Beckingham; E Hafen
Journal:  Cell       Date:  1999-06-25       Impact factor: 41.582

5.  Drosophila myc regulates cellular growth during development.

Authors:  L A Johnston; D A Prober; B A Edgar; R N Eisenman; P Gallant
Journal:  Cell       Date:  1999-09-17       Impact factor: 41.582

6.  PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.

Authors:  W Wick; F B Furnari; U Naumann; W K Cavenee; M Weller
Journal:  Oncogene       Date:  1999-07-08       Impact factor: 9.867

7.  Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms.

Authors:  Y Sanchez; J Bachant; H Wang; F Hu; D Liu; M Tetzlaff; S J Elledge
Journal:  Science       Date:  1999-11-05       Impact factor: 47.728

8.  Drosophila Cdk4 is required for normal growth and is dispensable for cell cycle progression.

Authors:  C A Meyer; H W Jacobs; S A Datar; W Du; B A Edgar; C F Lehner
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

9.  The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1.

Authors:  E C Busby; D F Leistritz; R T Abraham; L M Karnitz; J N Sarkaria
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

10.  Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.

Authors:  N H Chehab; A Malikzay; M Appel; T D Halazonetis
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

View more
  13 in total

1.  Linking model systems to cancer therapeutics: the case of Mastermind.

Authors:  Barry Yedvobnick; Ken Moberg
Journal:  Dis Model Mech       Date:  2010-07-27       Impact factor: 5.758

2.  Reduction of the background magnetic field inhibits ability of Drosophila melanogaster to survive ionizing radiation.

Authors:  Lucas A Portelli; Dinu R Madapatha; Carlos Martino; Mark Hernandez; Frank S Barnes
Journal:  Bioelectromagnetics       Date:  2012-04-24       Impact factor: 2.010

Review 3.  Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics.

Authors:  Cayetano Gonzalez
Journal:  Nat Rev Cancer       Date:  2013-02-07       Impact factor: 60.716

4.  HorkaD, a chromosome instability-causing mutation in Drosophila, is a dominant-negative allele of Lodestar.

Authors:  Tamas Szalontai; Imre Gaspar; Istvan Belecz; Iren Kerekes; Miklos Erdelyi; Imre Boros; Janos Szabad
Journal:  Genetics       Date:  2008-12-01       Impact factor: 4.562

5.  A translation inhibitor identified in a Drosophila screen enhances the effect of ionizing radiation and taxol in mammalian models of cancer.

Authors:  Mara Gladstone; Barbara Frederick; Di Zheng; Anthony Edwards; Petros Yoon; Stefanie Stickel; Tessie DeLaney; Daniel C Chan; David Raben; Tin Tin Su
Journal:  Dis Model Mech       Date:  2012-02-16       Impact factor: 5.758

6.  Combinatorial effect of maytansinol and radiation in Drosophila and human cancer cells.

Authors:  Anthony Edwards; Mara Gladstone; Petros Yoon; David Raben; Barbara Frederick; Tin Tin Su
Journal:  Dis Model Mech       Date:  2011-04-18       Impact factor: 5.758

7.  Altered radiation responses of breast cancer cells resistant to hormonal therapy.

Authors:  Lidiya Luzhna; Anne E Lykkesfeldt; Olga Kovalchuk
Journal:  Oncotarget       Date:  2015-01-30

8.  Common variants of Drosophila melanogaster Cyp6d2 cause camptothecin sensitivity and synergize with loss of Brca2.

Authors:  Adam M Thomas; Carrie Hui; Adam South; Mitch McVey
Journal:  G3 (Bethesda)       Date:  2013-01-01       Impact factor: 3.154

9.  Drosophila brca2 is required for mitotic and meiotic DNA repair and efficient activation of the meiotic recombination checkpoint.

Authors:  Martha Klovstad; Uri Abdu; Trudi Schüpbach
Journal:  PLoS Genet       Date:  2008-02       Impact factor: 5.917

10.  Overexpression of the Drosophila ATR homologous checkpoint kinase Mei-41 induces a G2/M checkpoint in Drosophila imaginal tissue.

Authors:  Fabienne E Bayer; Mirjam Zimmermann; Anette Preiss; Anja C Nagel
Journal:  Hereditas       Date:  2018-09-06       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.